New Search

If you are not happy with the results below please do another search

265 search results for: feed

181

Mental well-being of doctors: Here are NMC’s complete recommendations

New Delhi: The National Task Force, set up by the National Medical Commission’s (NMC) Anti-Ragging Committee has issued several recommendations to the medical colleges/institutes across the country to ensure proper mental health and well-being of medical students. In its report, the NMC ‘National Task Force on Mental Health and Well-being of Medical Students’, has opined that […]

182

Skin-to-skin ‘kangaroo care’ found to boost neurodevelopment in preemies, reports study

Skin-to-skin cuddling with a parent has lasting cognitive benefits for premature babies, according to a new Stanford Medicine study. Preemies who received more skin-to-skin contact, also known as kangaroo care, while hospitalized as newborns were less likely to be developmentally delayed at 1 year of age, the study found. The research, which was published online […]

183

Delhi AIIMS to roll out 20-seater e-buses to enhance patient transport on campus

New Delhi: The premiere health institution, the All India Institute of Medical Sciences (AIIMS) in New Delhi is set to introduce electric buses (eBuses) with an approximate capacity of 20 seats to enhance last-mile transport from nearby metro stations and bus stops to various facilities within the campus. This new service aims to address issues related […]

184

Wearable single use subcutaneous Furosemide Delivery System Under Review for Use in CKD Patients

The US Food and Drug Administration (FDA) has accepted supplemental New Drug Application for review of a pH-neutral formulation of furosemide, a loop diuretic, designed for subcutaneous (SC) administration via a , single-use wearable, pre-programmed on-body infusor for outpatient self-administration. This will expand the approval of furosemide injection to include treatment of edema due to […]

186

Digital mental health interventions may help decrease depression and anxiety symptoms before acive treatment: JAMA

A recent study conducted across various outpatient psychiatry clinics within the University of Michigan Health System revealed positive results regarding the effectiveness of digital mental health interventions (DMHIs) in the treatment of depression and anxiety. This randomized clinical trial spanned from May 2020 to December 2022 to compare the cognitive behavioral therapy (CBT)-based and mindfulness-based […]

187

High and low both concentrations of ropivacaine provide satisfactory labor epidural analgesia without any motor blockade: Study

Childbirth is commonly described as one of the most excruciating experiences for a woman, but medical advancements have significantly improved pain management during labor. Recent study aimed to evaluate the effectiveness of programmed intermittent epidural boluses (PIEBs) of ropivacaine in providing analgesia during labor. The researchers compared two different concentrations of ropivacaine (0.1% and 0.2%) […]

188

Innovative Smartphone Apps Show Promise in Reducing Distracted Driving: JAMA

USA: The three primary factors contributing to most fatal auto accidents are not wearing seat belts, distracted driving, and driving under the influence. Distracted driving, particularly due to cell phone use, represents a significant 21st-century threat that has yet to be sufficiently tackled. What’s a potential solution to smartphone distractions? A smartphone app! Research published […]

189

28 seats in 11 specialities, NBE Releases Centralised Merit-Based Counseling Schedule for FNB FPIS courses for International Students 2023 session

New Delhi- The National Board of Medical Examinations (NBEMS) has released the schedule for offline centralised merit-based counselling for international students- FNB Fellowship Programme for International Students (FPIS) courses for the 2023 admission session. The Centralised Merit Based Counseling for admission to FNB (FPIS) courses for the 2023 Admission Session will be conducted by NBEMS via […]

190

USFDA issues complete response letter for Patritumab Deruxtecan in EGFR-Mutated NSCLC: Merck, Daiichi Sankyo

Rahway: The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the Biologics License Application (BLA) seeking accelerated approval of Daiichi Sankyo and Merck’s (known as MSD outside of the United States and Canada) patritumab deruxtecan (HER3-DXd) for the treatment of adult patients with locally advanced or metastatic EGFR-mutated non-small cell […]